A benzodioxane alpha-adrenergic blocking agent with considerable stimulatory action. It has been used to diagnose PHEOCHROMOCYTOMA and as an antihypertensive agent.
Piperoxan has been studied across 13 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🌤️ Mood & Depression, 🫘 Kidney, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 33% of studies addressing this area.
The following compounds share molecular targets with Piperoxan, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Piperoxan is generated deterministically from 167 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.